Original Article
A sub-cluster of cancer cells indicates poor prognosis in advanced hepatocellular carcinoma
Chinese Clinical Oncology
2025;
14
(1)
:1
.
(28 February 2025)
Associations between dietary intake of zinc and selenium and breast cancer: findings from a NHANES cross-sectional study
Chinese Clinical Oncology
2025;
14
(1)
:2
.
(28 February 2025)
Comparative prognosis of liver transplantation versus liver resection in intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
Chinese Clinical Oncology
2025;
14
(1)
:3
.
(28 February 2025)
Novel treatment vs. standard of care in melanoma-associated leptomeningeal metastases: a systematic review and network meta-analysis
Chinese Clinical Oncology
2025;
14
(1)
:4
.
(28 February 2025)
Surgical Technique
Robotic-assisted trans-mesocolic side-to-side duodenojejunostomy for palliative management of malignant distal duodenal obstruction
Chinese Clinical Oncology
2025;
14
(1)
:5
.
(28 February 2025)
Review Article
Bibliometrics of gastric cancer prediction models
Chinese Clinical Oncology
2025;
14
(1)
:6
.
(28 February 2025)
Immunotherapy resistance in colorectal cancer with liver metastases: challenges & therapeutic advances
Chinese Clinical Oncology
2025;
14
(1)
:7
.
(28 February 2025)
Challenges and considerations in non-inferiority trials: a narrative review from statisticians’ perspectives
Chinese Clinical Oncology
2025;
14
(1)
:8
.
(28 February 2025)
Intriguing future: single-site robotic-assisted radical prostatectomy
Chinese Clinical Oncology
2025;
14
(1)
:9
.
(28 February 2025)
Pediatric radiotherapy preparation: a scoping review
Chinese Clinical Oncology
2025;
14
(1)
:10
.
(28 February 2025)
Case Report
A periungual eccrine poroma masquerading as amelanotic melanoma: a case report
Chinese Clinical Oncology
2025;
14
(1)
:11
.
(28 February 2025)
Editorial Commentary
Befotertinib: one more drug targeting EGFR—the more may be the merrier
Chinese Clinical Oncology
2025;
14
(1)
:12
.
(28 February 2025)
Is metastasis-directed local therapy the new standard of care for patients with oligometastasic esophageal squamous cell carcinoma?—a perspective on the ESO-Shanghai 13 Trial
Chinese Clinical Oncology
2025;
14
(1)
:13
.
(28 February 2025)
A new era for EGFR exon20 targeting in non-small cell lung cancer
Chinese Clinical Oncology
2025;
14
(1)
:14
.
(28 February 2025)
Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer
Chinese Clinical Oncology
2025;
14
(1)
:15
.
(28 February 2025)
